Medical Oncologist
Monitoring on sunitinib
Tests and Monitoring — While You Are on Sunitinib
Sunitinib affects several body systems beyond the tumour, and most of those changes are silent at first. Regular testing is how your team catches problems before they become serious — and how you stay on treatment safely.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- More than cancer monitoring — Blood pressure, thyroid function and heart health all need watching alongside tumour response.
- Silent changes — Many of the things sunitinib can affect do not cause obvious symptoms until they are significant.
- Tests protect treatment — Catching a change early usually means a dose adjustment, not stopping treatment altogether.
- You are part of this — Home blood pressure monitoring between appointments is one of the most important things you can do.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Sunitinib monitoring includes blood pressure checks, full blood counts, liver and kidney tests, thyroid levels, urine protein, and periodic heart scans. NCCN and ESMO guidelines recommend this testing because sunitinib can change each of these in ways that do not cause noticeable symptoms early. Finding a change in a test is what keeps treatment on track.
Why does sunitinib need so many different tests?
Sunitinib works by blocking signals that tumours use to grow and build blood vessels — and those same signals are active in healthy tissue in the heart, kidneys, thyroid gland and blood vessel walls, which is why monitoring covers all of these, not just the cancer.
The changes sunitinib causes in these systems often develop without any noticeable symptoms in the early stages. A blood pressure rise, a drop in thyroid hormones, or a fall in white cell count may feel like nothing at all until it becomes significant.
Regular tests are what keep your team one step ahead. When a result changes, the response is usually straightforward — a dose adjustment, a new medicine, or a short pause in treatment — rather than a crisis.
Which tests are done and what does each one mean?
| Test | When it is done | What is being watched | What may happen if it changes |
|---|---|---|---|
| Blood pressure | At every clinic visit; at home between visits | Sunitinib commonly raises blood pressure; sustained high readings increase cardiac risk | A blood pressure medicine may be added or adjusted; rarely, a dose pause is needed |
| Full blood count (CBC) | Before each new cycle | White cell count, platelet count and haemoglobin — all can fall on sunitinib | Low counts may delay the start of your next cycle until they recover |
| Liver function tests (LFTs) | Before each new cycle | Enzyme levels that show whether the liver is under stress | Raised levels usually prompt a dose reduction or a short treatment pause |
| Kidney function and electrolytes | Before each new cycle | Creatinine, potassium and other electrolytes — sunitinib can affect both | Electrolyte imbalance is corrected directly; significant kidney changes may need a dose review |
| Thyroid function (TSH) | Every two to three months, or sooner if fatigue worsens unexpectedly | Hypothyroidism — an underactive thyroid — is common with sunitinib and easily missed | Thyroid hormone replacement is straightforward to start and does not usually require a dose change |
| Urine protein | Periodically throughout treatment | Protein leaking into the urine, which signals stress on the kidney blood vessels | A small amount is often managed by monitoring; significant protein may need a dose adjustment |
| Heart function (echocardiogram) | At baseline before starting; then at agreed intervals | Left ventricular ejection fraction — how effectively the heart is pumping | If function falls, a cardiology review is arranged before treatment continues |
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
How does monitoring work across a sunitinib cycle?
Before your first tablet
Your team completes a baseline assessment — blood tests, blood pressure, an ECG, and usually an echocardiogram. These results are the benchmark everything later is compared against.
During your first weeks on treatment
Blood pressure monitoring begins at home, usually with a log your team provides. The first cycle is when rises most often appear. Check and record your readings at the times your team specifies.
At your cycle review appointment
Before each new cycle, a blood draw checks your full blood count, liver, kidney and electrolyte results. Your oncologist reviews these before authorising the next cycle to start.
Thyroid check every few months
A thyroid blood test is added to your routine at agreed intervals. Fatigue that feels worse than expected is worth mentioning to your team, as it is sometimes the first sign of low thyroid hormone.
Periodic heart scans
An echocardiogram is repeated at intervals agreed with your oncologist — more often if you had a heart condition before starting. This scan confirms the heart is pumping as it should.
Did you know?
Hypothyroidism — an underactive thyroid — develops in a significant proportion of people taking sunitinib long-term. It is one of the most common reasons for worsening fatigue during treatment, and it is frequently mistaken for the cancer itself or for general treatment exhaustion.
A simple blood test identifies it. Thyroid hormone replacement, once started, usually restores energy levels without any need to change the sunitinib dose.
Source: ESMO Clinical Practice Guidelines: Renal Cell Carcinoma
Explore 75 more Kidney, Ovarian & Sarcoma Targeted Medicines topics
Drug Deep Dive: Sunitinib (Sutent)
- Diet and Nutrition While on Sunitinib
- Drug, Food and Supplement Interactions With Sunitinib
- Fertility, Pregnancy and Contraception on Sunitinib
- Hand-Foot Skin Reaction on Sunitinib: Prevention From Day One
- How Does Sunitinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sunitinib Take to Work?
- How Long Will You Stay on Sunitinib?
- Mouth Sores, Taste Loss and Yellow Skin Discolouration on Sunitinib
- Sunitinib (Sutent, Sunitix): The Complete Patient Guide
- Sunitinib After Kidney Surgery and for GIST: Two Different Settings
- Sunitinib Myths: Hair Colour Change, Dose Cuts and 'Weaker Treatment'
- Sunitinib Price in India: Brand, Generic and Monthly Cost
- Sunitinib Side Effects: The Complete List and Timeline
- Sunitinib Success Rate and Survival: An Honest Look at the Numbers
- Sunitinib and Immunotherapy: Where Combinations Fit in Kidney Cancer
- Sunitinib in Elderly Patients and Those With Other Illnesses
- Sunitinib vs Pazopanib vs Cabozantinib for Kidney Cancer
- Taking Sunitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sunitinib
- The 4-Weeks-On, 2-Weeks-Off Sunitinib Schedule and the 2/1 Alternative
- Thyroid Failure and Fatigue on Sunitinib: The Test to Repeat Every Cycle
- When Sunitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sunitinib? Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumours
- Will Insurance or a Government Scheme Pay for Sunitinib?
- Work, Travel and Daily Life on Sunitinib
Drug Deep Dive: Olaparib (Lynparza)
- Adjuvant Olaparib After Early Breast Cancer Surgery
- Anaemia and Extreme Fatigue on Olaparib
- Blood Cancer Risk After Long-Term Olaparib: How Real Is It?
- Diet and Nutrition While on Olaparib
- Drug, Food and Supplement Interactions With Olaparib
- Fertility, Pregnancy and Contraception on Olaparib
- How Does Olaparib Work? The PARP Inhibitor Explained
- How Long Does Olaparib Take to Work?
- How Long Will You Stay on Olaparib?
- Maintenance Olaparib: Taking a Drug When There Is No Visible Cancer
- Nausea on Olaparib: Managing the Most Common Side Effect
- Olaparib (Lynparza, Olanib): The Complete Patient Guide
- Olaparib Myths: 'Only for BRCA', 'It's Chemo', 'It Causes Cancer'
- Olaparib Price in India: Brand, Generic and Monthly Cost
- Olaparib Side Effects: The Complete List and Timeline
- Olaparib Success Rate and Survival: An Honest Look at the Numbers
- Olaparib With Bevacizumab or Hormone Therapy: Combination Regimens
- Olaparib in Elderly Patients and Those With Other Illnesses
- Olaparib vs Niraparib vs Talazoparib: Comparing PARP Inhibitors
- Taking Olaparib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Olaparib
- When Olaparib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Olaparib? BRCA-Mutated Ovarian, Breast, Prostate and Pancreatic Cancer
- Will Insurance or a Government Scheme Pay for Olaparib?
- Work, Travel and Daily Life on Olaparib
Drug Deep Dive: Pazopanib (Votrient)
- Diarrhoea and Blood Pressure Rise on Pazopanib
- Diet and Nutrition While on Pazopanib
- Drug, Food and Supplement Interactions With Pazopanib
- Fertility, Pregnancy and Contraception on Pazopanib
- Hair Turning White and Skin Lightening on Pazopanib
- How Does Pazopanib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Pazopanib Take to Work?
- How Long Will You Stay on Pazopanib?
- Liver Toxicity on Pazopanib: Why LFTs Are Checked Every Two Weeks
- Pazopanib (Votrient, Pazonib): The Complete Patient Guide
- Pazopanib Combinations: Why It Is Usually Given Alone
- Pazopanib Myths: Hair Colour, Liver Damage and Stopping Early
- Pazopanib Price in India: Brand, Generic and Monthly Cost
- Pazopanib Side Effects: The Complete List and Timeline
- Pazopanib Success Rate and Survival: An Honest Look at the Numbers
- Pazopanib for Soft Tissue Sarcoma: What It Can and Cannot Do
- Pazopanib in Elderly Patients and Those With Other Illnesses
- Pazopanib in Kidney Cancer vs Sarcoma: Two Different Treatment Goals
- Pazopanib vs Sunitinib: Comparing Toxicity and Quality of Life
- Taking Pazopanib on an Empty Stomach: Why the Timing Rule Exists
- Tests and Monitoring While You Are on Pazopanib
- When Pazopanib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Pazopanib? Kidney Cancer and Soft Tissue Sarcoma
- Will Insurance or a Government Scheme Pay for Pazopanib?
- Work, Travel and Daily Life on Pazopanib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Can I skip a blood test if I feel completely well?
Feeling well is genuinely good news, but it is not a reliable guide to what a blood test would show. The most important things sunitinib monitoring catches — a fall in blood counts, early liver stress, a thyroid problem — often cause no symptoms at all in the early stages. Your team needs the result, not just your self-assessment, to decide it is safe to start the next cycle. Missing a test also means your oncologist is authorising treatment without the information they need to do so safely.
My blood pressure has gone up since starting sunitinib. Should I stop taking it?
Do not stop sunitinib on your own because of a blood pressure reading. High blood pressure is a common and manageable effect of the drug, and your team can add or adjust a blood pressure medicine to bring it back to a safe range. Stopping sunitinib without advice means losing a treatment that may be working. Report the reading to your team today so they can decide what adjustment is needed — do not wait for your next scheduled appointment.
Why do I need a heart scan before I even start?
The echocardiogram done before your first tablet establishes a baseline — a measurement of how well your heart is pumping before sunitinib has had any effect. Without that starting point, your team cannot tell whether any change during treatment is caused by the drug or was already present beforehand. If heart function falls during treatment, the baseline is what tells them how much it has changed and how urgently they need to act.
How do I monitor my blood pressure at home correctly?
Use a validated upper-arm cuff rather than a wrist device, which is less accurate. Sit quietly for five minutes before measuring, and take the reading at roughly the same time each day. Record each reading with the date and time — a small notebook or a phone note works well. Bring the log to every appointment. Ask your team to write down the specific reading that should prompt you to call them, because that threshold is personal to you and your other health conditions.
What happens if one of my test results comes back abnormal?
An abnormal result does not automatically mean treatment stops. The response depends on which test has changed, how far out of range it is, and whether you have any symptoms alongside it. Common responses include a short treatment pause to let the value recover, a reduction to the next standard dose level, or adding a medicine to manage the effect while sunitinib continues. Your oncologist will explain what the specific result means for your situation. Do not adjust anything yourself before that conversation.